Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,929 | -934 | -2,255 | -3,087 | -1,912 |
| Depreciation Amortization | 19 | 7 | 107 | 98 | 50 |
| Other Working Capital | 403 | 74 | 128 | 301 | 198 |
| Other Operating Activity | 48 | 15 | 85 | 82 | 43 |
| Operating Cash Flow | $-1,458 | $-838 | $-1,936 | $-2,606 | $-1,621 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,990 | 1,990 | 1,990 |
| PPE Investments | 2 | 5 | 41 | 17 | 13 |
| Investing Cash Flow | $2 | $5 | $2,031 | $2,007 | $2,003 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 400 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | N/A | 500 | N/A | N/A |
| Other Financing Activity | -21 | 0 | -22 | 0 | 0 |
| Financing Cash Flow | $378 | $N/A | $478 | $0 | $0 |
| Beginning Cash Position | 1,611 | 1,611 | 1,038 | 1,038 | 1,038 |
| End Cash Position | 533 | 778 | 1,611 | 438 | 1,420 |
| Net Cash Flow | $-1,078 | $-833 | $573 | $-599 | $382 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,458 | -838 | -1,936 | -2,606 | -1,621 |
| Capital Expenditure | -5 | N/A | N/A | 0 | 0 |
| Free Cash Flow | -1,463 | -838 | -1,936 | -2,606 | -1,621 |